{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T09:18:26Z","timestamp":1794561506203,"version":"4.9.1"},"reference-count":46,"publisher":"Archives of Pathology and Laboratory Medicine","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,2,1]]},"abstract":"<jats:sec>\n                    <jats:title>Context.\u2014<\/jats:title>\n                    <jats:p>Langerhans cell histiocytosis (LCH) is a rare myeloid neoplasm that predominantly affects young children.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective.\u2014<\/jats:title>\n                    <jats:p>To investigate genetic alterations and their correlation with clinical characteristics and prognosis in pediatric LCH.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design.\u2014<\/jats:title>\n                    <jats:p>We performed targeted sequencing to detect mutations in LCH lesions from pediatric patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results.\u2014<\/jats:title>\n                    <jats:p>A total of 30 genomic alterations in 5 genes of the MAPK pathway were identified in 187 of 223 patients (83.9%). BRAF V600E (B-Raf proto-oncogene, serine\/threonine kinase) was the most common mutation (51.6%), followed by MAP2K1 (mitogen-activated protein kinase kinase 1) alterations (17.0%) and other BRAF mutations (13.0%). ARAF (A-Raf proto-oncogene, serine\/threonine kinase) and KRAS (KRAS proto-oncogene, GTPase) mutations were relatively rare (2.2% and 0.9%, respectively). Additionally, FNBP1 (formin-binding protein 1)::BRAF fusion and MAP3K10 (mitogen-activated protein kinase kinase 10) mutations A17T and R823C were identified in 1 case each, with possible constitutive activation of ERK1\/2 phosphorylation. BRAF V600E was more frequent in patients with risk organ involvement, while MAP2K1 mutation was more prevalent in patients with single-system LCH (P = .001). BRAF V600E was associated with craniofacial bone, skin, liver, spleen, and ear involvement (all P &amp;lt; .05). Patients with other BRAF mutations had a higher proportion of spinal column involvement (P = .006). Univariate analysis showed a significant difference in progression-free survival among the 4 molecular subgroups for patients treated with first-line therapy (P = .02). According to multivariate analysis, risk organ involvement was the strongest independent adverse prognostic factor (hazard ratio, 8.854; P &amp;lt; .001); BRAF or MAP2K1 mutation was not an independent prognostic factor.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions.\u2014<\/jats:title>\n                    <jats:p>Most pediatric patients with LCH carry somatic mutations involving the MAPK pathway, correlating with clinical characteristics and outcomes for first-line chemotherapy.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.5858\/arpa.2023-0236-oa","type":"journal-article","created":{"date-parts":[[2024,5,15]],"date-time":"2024-05-15T20:00:43Z","timestamp":1715803243000},"page":"175-190","source":"Crossref","is-referenced-by-count":10,"title":["Genetic Landscape and Its Prognostic Impact in Children With Langerhans Cell Histiocytosis"],"prefix":"10.5858","volume":"149","author":[{"given":"Chan-Juan","family":"Wang","sequence":"first","affiliation":[{"name":"From the Laboratory of Hematologic Diseases, Beijing Pediatric Research Institute (C-J Wang, Cui, W-J Li, Q Zhang, X-X Zhao, Huang, Z-G Li) and Beijing Key Laboratory of Pediatric Hematology Oncology, Hematology Center (C-J Wang, Cui, Ma, D Wang, Lian, Y-Z Zhao, L-P Zhang, W-J Li, Q Zhang, X-X Zhao, Yang, Huang, T-Y Wang, R Zhang, Z-G Li), Beijing Children\u2019s Hospital, Capital Medical University, National Center for Children\u2019s Health, Beijing, China"},{"name":"National Key Discipline of Pediatrics, Capital Medical University, Beijing, China (C-J Wang, Cui, Ma, D Wang, Lian, Y-Z Zhao, L-P Zhang, W-J Li, Q Zhang, X-X Zhao, Yang, Huang, T-Y Wang, R Zhang, Z-G Li)"},{"name":"Key Laboratory of Major Diseases in Children, Ministry of Education, Beijing, China (C-J Wang, Cui, Ma, D Wang, Lian, Y-Z Zhao, L-P Zhang, W-J Li, Q Zhang, X-X Zhao, Yang, Huang, T-Y Wang, R Zhang, Z-G Li)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Cui","sequence":"additional","affiliation":[{"name":"From the Laboratory of Hematologic Diseases, Beijing Pediatric Research Institute (C-J Wang, Cui, W-J Li, Q Zhang, X-X Zhao, Huang, Z-G Li) and Beijing Key Laboratory of Pediatric Hematology Oncology, Hematology Center (C-J Wang, Cui, Ma, D Wang, Lian, Y-Z Zhao, L-P Zhang, W-J Li, Q Zhang, X-X Zhao, Yang, Huang, T-Y Wang, R Zhang, Z-G Li), Beijing Children\u2019s Hospital, Capital Medical University, National Center for Children\u2019s Health, Beijing, China"},{"name":"National Key Discipline of Pediatrics, Capital Medical University, Beijing, China (C-J Wang, Cui, Ma, D Wang, Lian, Y-Z Zhao, L-P Zhang, W-J Li, Q Zhang, X-X Zhao, Yang, Huang, T-Y Wang, R Zhang, Z-G Li)"},{"name":"Key Laboratory of Major Diseases in Children, Ministry of Education, Beijing, China (C-J Wang, Cui, Ma, D Wang, Lian, Y-Z Zhao, L-P Zhang, W-J Li, Q Zhang, X-X Zhao, Yang, Huang, T-Y Wang, R Zhang, Z-G Li)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuang-Shuang","family":"Li","sequence":"additional","affiliation":[{"name":"MyGenostics Inc, Beijing, China (S-S Li)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong-Hao","family":"Ma","sequence":"additional","affiliation":[{"name":"From the Laboratory of Hematologic Diseases, Beijing Pediatric Research Institute (C-J Wang, Cui, W-J Li, Q Zhang, X-X Zhao, Huang, Z-G Li) and Beijing Key Laboratory of Pediatric Hematology Oncology, Hematology Center (C-J Wang, Cui, Ma, D Wang, Lian, Y-Z Zhao, L-P Zhang, W-J Li, Q Zhang, X-X Zhao, Yang, Huang, T-Y Wang, R Zhang, Z-G Li), Beijing Children\u2019s Hospital, Capital Medical University, National Center for Children\u2019s Health, Beijing, China"},{"name":"National Key Discipline of Pediatrics, Capital Medical University, Beijing, China (C-J Wang, Cui, Ma, D Wang, Lian, Y-Z Zhao, L-P Zhang, W-J Li, Q Zhang, X-X Zhao, Yang, Huang, T-Y Wang, R Zhang, Z-G Li)"},{"name":"Key Laboratory of Major Diseases in Children, Ministry of Education, Beijing, China (C-J Wang, Cui, Ma, D Wang, Lian, Y-Z Zhao, L-P Zhang, W-J Li, Q Zhang, X-X Zhao, Yang, Huang, T-Y Wang, R Zhang, Z-G Li)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong","family":"Wang","sequence":"additional","affiliation":[{"name":"From the Laboratory of Hematologic Diseases, Beijing Pediatric Research Institute (C-J Wang, Cui, W-J Li, Q Zhang, X-X Zhao, Huang, Z-G Li) and Beijing Key Laboratory of Pediatric Hematology Oncology, Hematology Center (C-J Wang, Cui, Ma, D Wang, Lian, Y-Z Zhao, L-P Zhang, W-J Li, Q Zhang, X-X Zhao, Yang, Huang, T-Y Wang, R Zhang, Z-G Li), Beijing Children\u2019s Hospital, Capital Medical University, National Center for Children\u2019s Health, Beijing, China"},{"name":"National Key Discipline of Pediatrics, Capital Medical University, Beijing, China (C-J Wang, Cui, Ma, D Wang, Lian, Y-Z Zhao, L-P Zhang, W-J Li, Q Zhang, X-X Zhao, Yang, Huang, T-Y Wang, R Zhang, Z-G Li)"},{"name":"Key Laboratory of Major Diseases in Children, Ministry of Education, Beijing, China (C-J Wang, Cui, Ma, D Wang, Lian, Y-Z Zhao, L-P Zhang, W-J Li, Q Zhang, X-X Zhao, Yang, Huang, T-Y Wang, R Zhang, Z-G Li)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong-Yun","family":"Lian","sequence":"additional","affiliation":[{"name":"From the Laboratory of Hematologic Diseases, Beijing Pediatric Research Institute (C-J Wang, Cui, W-J Li, Q Zhang, X-X Zhao, Huang, Z-G Li) and Beijing Key Laboratory of Pediatric Hematology Oncology, Hematology Center (C-J Wang, Cui, Ma, D Wang, Lian, Y-Z Zhao, L-P Zhang, W-J Li, Q Zhang, X-X Zhao, Yang, Huang, T-Y Wang, R Zhang, Z-G Li), Beijing Children\u2019s Hospital, Capital Medical University, National Center for Children\u2019s Health, Beijing, China"},{"name":"National Key Discipline of Pediatrics, Capital Medical University, Beijing, China (C-J Wang, Cui, Ma, D Wang, Lian, Y-Z Zhao, L-P Zhang, W-J Li, Q Zhang, X-X Zhao, Yang, Huang, T-Y Wang, R Zhang, Z-G Li)"},{"name":"Key Laboratory of Major Diseases in Children, Ministry of Education, Beijing, China (C-J Wang, Cui, Ma, D Wang, Lian, Y-Z Zhao, L-P Zhang, W-J Li, Q Zhang, X-X Zhao, Yang, Huang, T-Y Wang, R Zhang, Z-G Li)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun-Ze","family":"Zhao","sequence":"additional","affiliation":[{"name":"From the Laboratory of Hematologic Diseases, Beijing Pediatric Research Institute (C-J Wang, Cui, W-J Li, Q Zhang, X-X Zhao, Huang, Z-G Li) and Beijing Key Laboratory of Pediatric Hematology Oncology, Hematology Center (C-J Wang, Cui, Ma, D Wang, Lian, Y-Z Zhao, L-P Zhang, W-J Li, Q Zhang, X-X Zhao, Yang, Huang, T-Y Wang, R Zhang, Z-G Li), Beijing Children\u2019s Hospital, Capital Medical University, National Center for Children\u2019s Health, Beijing, China"},{"name":"National Key Discipline of Pediatrics, Capital Medical University, Beijing, China (C-J Wang, Cui, Ma, D Wang, Lian, Y-Z Zhao, L-P Zhang, W-J Li, Q Zhang, X-X Zhao, Yang, Huang, T-Y Wang, R Zhang, Z-G Li)"},{"name":"Key Laboratory of Major Diseases in Children, Ministry of Education, Beijing, China (C-J Wang, Cui, Ma, D Wang, Lian, Y-Z Zhao, L-P Zhang, W-J Li, Q Zhang, X-X Zhao, Yang, Huang, T-Y Wang, R Zhang, Z-G Li)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-Ping","family":"Zhang","sequence":"additional","affiliation":[{"name":"From the Laboratory of Hematologic Diseases, Beijing Pediatric Research Institute (C-J Wang, Cui, W-J Li, Q Zhang, X-X Zhao, Huang, Z-G Li) and Beijing Key Laboratory of Pediatric Hematology Oncology, Hematology Center (C-J Wang, Cui, Ma, D Wang, Lian, Y-Z Zhao, L-P Zhang, W-J Li, Q Zhang, X-X Zhao, Yang, Huang, T-Y Wang, R Zhang, Z-G Li), Beijing Children\u2019s Hospital, Capital Medical University, National Center for Children\u2019s Health, Beijing, China"},{"name":"National Key Discipline of Pediatrics, Capital Medical University, Beijing, China (C-J Wang, Cui, Ma, D Wang, Lian, Y-Z Zhao, L-P Zhang, W-J Li, Q Zhang, X-X Zhao, Yang, Huang, T-Y Wang, R Zhang, Z-G Li)"},{"name":"Key Laboratory of Major Diseases in Children, Ministry of Education, Beijing, China (C-J Wang, Cui, Ma, D Wang, Lian, Y-Z Zhao, L-P Zhang, W-J Li, Q Zhang, X-X Zhao, Yang, Huang, T-Y Wang, R Zhang, Z-G Li)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-Jing","family":"Li","sequence":"additional","affiliation":[{"name":"From the Laboratory of Hematologic Diseases, Beijing Pediatric Research Institute (C-J Wang, Cui, W-J Li, Q Zhang, X-X Zhao, Huang, Z-G Li) and Beijing Key Laboratory of Pediatric Hematology Oncology, Hematology Center (C-J Wang, Cui, Ma, D Wang, Lian, Y-Z Zhao, L-P Zhang, W-J Li, Q Zhang, X-X Zhao, Yang, Huang, T-Y Wang, R Zhang, Z-G Li), Beijing Children\u2019s Hospital, Capital Medical University, National Center for Children\u2019s Health, Beijing, China"},{"name":"National Key Discipline of Pediatrics, Capital Medical University, Beijing, China (C-J Wang, Cui, Ma, D Wang, Lian, Y-Z Zhao, L-P Zhang, W-J Li, Q Zhang, X-X Zhao, Yang, Huang, T-Y Wang, R Zhang, Z-G Li)"},{"name":"Key Laboratory of Major Diseases in Children, Ministry of Education, Beijing, China (C-J Wang, Cui, Ma, D Wang, Lian, Y-Z Zhao, L-P Zhang, W-J Li, Q Zhang, X-X Zhao, Yang, Huang, T-Y Wang, R Zhang, Z-G Li)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Zhang","sequence":"additional","affiliation":[{"name":"From the Laboratory of Hematologic Diseases, Beijing Pediatric Research Institute (C-J Wang, Cui, W-J Li, Q Zhang, X-X Zhao, Huang, Z-G Li) and Beijing Key Laboratory of Pediatric Hematology Oncology, Hematology Center (C-J Wang, Cui, Ma, D Wang, Lian, Y-Z Zhao, L-P Zhang, W-J Li, Q Zhang, X-X Zhao, Yang, Huang, T-Y Wang, R Zhang, Z-G Li), Beijing Children\u2019s Hospital, Capital Medical University, National Center for Children\u2019s Health, Beijing, China"},{"name":"National Key Discipline of Pediatrics, Capital Medical University, Beijing, China (C-J Wang, Cui, Ma, D Wang, Lian, Y-Z Zhao, L-P Zhang, W-J Li, Q Zhang, X-X Zhao, Yang, Huang, T-Y Wang, R Zhang, Z-G Li)"},{"name":"Key Laboratory of Major Diseases in Children, Ministry of Education, Beijing, China (C-J Wang, Cui, Ma, D Wang, Lian, Y-Z Zhao, L-P Zhang, W-J Li, Q Zhang, X-X Zhao, Yang, Huang, T-Y Wang, R Zhang, Z-G Li)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Xi","family":"Zhao","sequence":"additional","affiliation":[{"name":"From the Laboratory of Hematologic Diseases, Beijing Pediatric Research Institute (C-J Wang, Cui, W-J Li, Q Zhang, X-X Zhao, Huang, Z-G Li) and Beijing Key Laboratory of Pediatric Hematology Oncology, Hematology Center (C-J Wang, Cui, Ma, D Wang, Lian, Y-Z Zhao, L-P Zhang, W-J Li, Q Zhang, X-X Zhao, Yang, Huang, T-Y Wang, R Zhang, Z-G Li), Beijing Children\u2019s Hospital, Capital Medical University, National Center for Children\u2019s Health, Beijing, China"},{"name":"National Key Discipline of Pediatrics, Capital Medical University, Beijing, China (C-J Wang, Cui, Ma, D Wang, Lian, Y-Z Zhao, L-P Zhang, W-J Li, Q Zhang, X-X Zhao, Yang, Huang, T-Y Wang, R Zhang, Z-G Li)"},{"name":"Key Laboratory of Major Diseases in Children, Ministry of Education, Beijing, China (C-J Wang, Cui, Ma, D Wang, Lian, Y-Z Zhao, L-P Zhang, W-J Li, Q Zhang, X-X Zhao, Yang, Huang, T-Y Wang, R Zhang, Z-G Li)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Yang","sequence":"additional","affiliation":[{"name":"From the Laboratory of Hematologic Diseases, Beijing Pediatric Research Institute (C-J Wang, Cui, W-J Li, Q Zhang, X-X Zhao, Huang, Z-G Li) and Beijing Key Laboratory of Pediatric Hematology Oncology, Hematology Center (C-J Wang, Cui, Ma, D Wang, Lian, Y-Z Zhao, L-P Zhang, W-J Li, Q Zhang, X-X Zhao, Yang, Huang, T-Y Wang, R Zhang, Z-G Li), Beijing Children\u2019s Hospital, Capital Medical University, National Center for Children\u2019s Health, Beijing, China"},{"name":"National Key Discipline of Pediatrics, Capital Medical University, Beijing, China (C-J Wang, Cui, Ma, D Wang, Lian, Y-Z Zhao, L-P Zhang, W-J Li, Q Zhang, X-X Zhao, Yang, Huang, T-Y Wang, R Zhang, Z-G Li)"},{"name":"Key Laboratory of Major Diseases in Children, Ministry of Education, Beijing, China (C-J Wang, Cui, Ma, D Wang, Lian, Y-Z Zhao, L-P Zhang, W-J Li, Q Zhang, X-X Zhao, Yang, Huang, T-Y Wang, R Zhang, Z-G Li)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Tong","family":"Huang","sequence":"additional","affiliation":[{"name":"From the Laboratory of Hematologic Diseases, Beijing Pediatric Research Institute (C-J Wang, Cui, W-J Li, Q Zhang, X-X Zhao, Huang, Z-G Li) and Beijing Key Laboratory of Pediatric Hematology Oncology, Hematology Center (C-J Wang, Cui, Ma, D Wang, Lian, Y-Z Zhao, L-P Zhang, W-J Li, Q Zhang, X-X Zhao, Yang, Huang, T-Y Wang, R Zhang, Z-G Li), Beijing Children\u2019s Hospital, Capital Medical University, National Center for Children\u2019s Health, Beijing, China"},{"name":"National Key Discipline of Pediatrics, Capital Medical University, Beijing, China (C-J Wang, Cui, Ma, D Wang, Lian, Y-Z Zhao, L-P Zhang, W-J Li, Q Zhang, X-X Zhao, Yang, Huang, T-Y Wang, R Zhang, Z-G Li)"},{"name":"Key Laboratory of Major Diseases in Children, Ministry of Education, Beijing, China (C-J Wang, Cui, Ma, D Wang, Lian, Y-Z Zhao, L-P Zhang, W-J Li, Q Zhang, X-X Zhao, Yang, Huang, T-Y Wang, R Zhang, Z-G Li)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Liu","sequence":"additional","affiliation":[{"name":"the Department of Hematology Oncology, Children\u2019s Hospital Affiliated to Zhengzhou University, Zhengzhou University, Zhengzhou, China (Liu)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Zhuo","family":"Wang","sequence":"additional","affiliation":[{"name":"the Department of Pediatrics, Beijing Tongren Hospital, Capital Medical University, Beijing, China (Y-Z Wang)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wan-Shui","family":"Wu","sequence":"additional","affiliation":[{"name":"and the Department of Pediatrics, Beijing Shijitan Hospital, Capital Medical University, Beijing, China (Wu)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tian-You","family":"Wang","sequence":"additional","affiliation":[{"name":"From the Laboratory of Hematologic Diseases, Beijing Pediatric Research Institute (C-J Wang, Cui, W-J Li, Q Zhang, X-X Zhao, Huang, Z-G Li) and Beijing Key Laboratory of Pediatric Hematology Oncology, Hematology Center (C-J Wang, Cui, Ma, D Wang, Lian, Y-Z Zhao, L-P Zhang, W-J Li, Q Zhang, X-X Zhao, Yang, Huang, T-Y Wang, R Zhang, Z-G Li), Beijing Children\u2019s Hospital, Capital Medical University, National Center for Children\u2019s Health, Beijing, China"},{"name":"National Key Discipline of Pediatrics, Capital Medical University, Beijing, China (C-J Wang, Cui, Ma, D Wang, Lian, Y-Z Zhao, L-P Zhang, W-J Li, Q Zhang, X-X Zhao, Yang, Huang, T-Y Wang, R Zhang, Z-G Li)"},{"name":"Key Laboratory of Major Diseases in Children, Ministry of Education, Beijing, China (C-J Wang, Cui, Ma, D Wang, Lian, Y-Z Zhao, L-P Zhang, W-J Li, Q Zhang, X-X Zhao, Yang, Huang, T-Y Wang, R Zhang, Z-G Li)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Zhang","sequence":"additional","affiliation":[{"name":"From the Laboratory of Hematologic Diseases, Beijing Pediatric Research Institute (C-J Wang, Cui, W-J Li, Q Zhang, X-X Zhao, Huang, Z-G Li) and Beijing Key Laboratory of Pediatric Hematology Oncology, Hematology Center (C-J Wang, Cui, Ma, D Wang, Lian, Y-Z Zhao, L-P Zhang, W-J Li, Q Zhang, X-X Zhao, Yang, Huang, T-Y Wang, R Zhang, Z-G Li), Beijing Children\u2019s Hospital, Capital Medical University, National Center for Children\u2019s Health, Beijing, China"},{"name":"National Key Discipline of Pediatrics, Capital Medical University, Beijing, China (C-J Wang, Cui, Ma, D Wang, Lian, Y-Z Zhao, L-P Zhang, W-J Li, Q Zhang, X-X Zhao, Yang, Huang, T-Y Wang, R Zhang, Z-G Li)"},{"name":"Key Laboratory of Major Diseases in Children, Ministry of Education, Beijing, China (C-J Wang, Cui, Ma, D Wang, Lian, Y-Z Zhao, L-P Zhang, W-J Li, Q Zhang, X-X Zhao, Yang, Huang, T-Y Wang, R Zhang, Z-G Li)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi-Gang","family":"Li","sequence":"additional","affiliation":[{"name":"From the Laboratory of Hematologic Diseases, Beijing Pediatric Research Institute (C-J Wang, Cui, W-J Li, Q Zhang, X-X Zhao, Huang, Z-G Li) and Beijing Key Laboratory of Pediatric Hematology Oncology, Hematology Center (C-J Wang, Cui, Ma, D Wang, Lian, Y-Z Zhao, L-P Zhang, W-J Li, Q Zhang, X-X Zhao, Yang, Huang, T-Y Wang, R Zhang, Z-G Li), Beijing Children\u2019s Hospital, Capital Medical University, National Center for Children\u2019s Health, Beijing, China"},{"name":"National Key Discipline of Pediatrics, Capital Medical University, Beijing, China (C-J Wang, Cui, Ma, D Wang, Lian, Y-Z Zhao, L-P Zhang, W-J Li, Q Zhang, X-X Zhao, Yang, Huang, T-Y Wang, R Zhang, Z-G Li)"},{"name":"Key Laboratory of Major Diseases in Children, Ministry of Education, Beijing, China (C-J Wang, Cui, Ma, D Wang, Lian, Y-Z Zhao, L-P Zhang, W-J Li, Q Zhang, X-X Zhao, Yang, Huang, T-Y Wang, R Zhang, Z-G Li)"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"3906","published-online":{"date-parts":[[2024,5,16]]},"reference":[{"issue":"9","key":"2025012723511472100_i1543-2165-149-2-175-b01","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1056\/NEJMra1607548","article-title":"Langerhans-cell histiocytosis","volume":"379","author":"Allen","year":"2018","journal-title":"N Engl J Med"},{"issue":"16","key":"2025012723511472100_i1543-2165-149-2-175-b02","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1182\/blood.2019000934","article-title":"Langerhans cell histiocytosis","volume":"135","author":"Rodriguez-Galindo","year":"2020","journal-title":"Blood"},{"issue":"6","key":"2025012723511472100_i1543-2165-149-2-175-b03","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1111\/bjh.14140","article-title":"Langerhans cell histiocytosis: therapeutic strategy and outcome in a 30-year nationwide cohort of 1478 patients under 18 years of age","volume":"174","author":"Rigaud","year":"2016","journal-title":"Br J Haematol"},{"issue":"1","key":"2025012723511472100_i1543-2165-149-2-175-b04","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41590-019-0558-z","article-title":"The coming of age of Langerhans cell histiocytosis","volume":"21","author":"Allen","year":"2020","journal-title":"Nat Immunol"},{"issue":"21","key":"2025012723511472100_i1543-2165-149-2-175-b05","doi-asserted-by":"crossref","first-page":"2533","DOI":"10.1182\/blood-2016-08-733790","article-title":"Alternative genetic mechanisms of BRAF activation in Langerhans cell histiocytosis","volume":"128","author":"Chakraborty","year":"2016","journal-title":"Blood"},{"issue":"1","key":"2025012723511472100_i1543-2165-149-2-175-b06","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1186\/s12943-017-0690-z","article-title":"New somatic BRAF splicing mutation in Langerhans cell histiocytosis","volume":"16","author":"Heritier","year":"2017","journal-title":"Mol Cancer"},{"issue":"11","key":"2025012723511472100_i1543-2165-149-2-175-b07","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1182\/blood-2010-04-279083","article-title":"Recurrent BRAF mutations in Langerhans cell histiocytosis","volume":"116","author":"Badalian-Very","year":"2010","journal-title":"Blood"},{"issue":"4","key":"2025012723511472100_i1543-2165-149-2-175-b08","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1084\/jem.20130977","article-title":"BRAF-V600E expression in precursor versus differentiated dendritic cells defines clinically distinct LCH risk groups","volume":"211","author":"Berres","year":"2014","journal-title":"J Exp Med"},{"issue":"19","key":"2025012723511472100_i1543-2165-149-2-175-b09","doi-asserted-by":"crossref","first-page":"3007","DOI":"10.1182\/blood-2014-05-577825","article-title":"Mutually exclusive recurrent somatic mutations in MAP2K1 and BRAF support a central role for ERK activation in LCH pathogenesis","volume":"124","author":"Chakraborty","year":"2014","journal-title":"Blood"},{"issue":"20","key":"2025012723511472100_i1543-2165-149-2-175-b10","doi-asserted-by":"crossref","first-page":"3152","DOI":"10.1182\/blood-2013-06-511139","article-title":"Somatic activating ARAF mutations in Langerhans cell histiocytosis","volume":"123","author":"Nelson","year":"2014","journal-title":"Blood"},{"issue":"2","key":"2025012723511472100_i1543-2165-149-2-175-b11","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1158\/2159-8290.CD-15-0913","article-title":"Diverse and targetable kinase alterations drive histiocytic neoplasms","volume":"6","author":"Diamond","year":"2016","journal-title":"Cancer Discov"},{"issue":"15","key":"2025012723511472100_i1543-2165-149-2-175-b12","doi-asserted-by":"crossref","first-page":"2448","DOI":"10.1182\/blood-2015-01-625491","article-title":"Common cancer-associated PIK3CA activating mutations rarely occur in Langerhans cell histiocytosis","volume":"125","author":"H\u00e9ritier","year":"2015","journal-title":"Blood"},{"issue":"25","key":"2025012723511472100_i1543-2165-149-2-175-b13","doi-asserted-by":"crossref","first-page":"3023","DOI":"10.1200\/JCO.2015.65.9508","article-title":"BRAF mutation correlates with high-risk Langerhans cell histiocytosis and increased resistance to first-line therapy","volume":"34","author":"Heritier","year":"2016","journal-title":"J Clin Oncol"},{"issue":"4","key":"2025012723511472100_i1543-2165-149-2-175-b14","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1111\/bjh.15577","article-title":"Incidence and risk factors for clinical neurodegenerative Langerhans cell histiocytosis: a longitudinal cohort study","volume":"183","author":"Heritier","year":"2018","journal-title":"Br J Haematol"},{"issue":"10","key":"2025012723511472100_i1543-2165-149-2-175-b15","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1182\/blood-2014-05-577361","article-title":"High prevalence of somatic MAP2K1 mutations in BRAF V600E-negative Langerhans cell histiocytosis","volume":"124","author":"Brown","year":"2014","journal-title":"Blood"},{"issue":"4","key":"2025012723511472100_i1543-2165-149-2-175-b16","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1002\/ajh.26829","article-title":"Clinical outcomes and prognostic risk factors of Langerhans cell histiocytosis in children: results from the BCH-LCH 2014 protocol study","volume":"98","author":"Cui","year":"2023","journal-title":"Am J Hematol"},{"issue":"25","key":"2025012723511472100_i1543-2165-149-2-175-b17","doi-asserted-by":"crossref","first-page":"5006","DOI":"10.1182\/blood-2012-09-455774","article-title":"Therapy prolongation improves outcome in multisystem Langerhans cell histiocytosis","volume":"121","author":"Gadner","year":"2013","journal-title":"Blood"},{"issue":"3","key":"2025012723511472100_i1543-2165-149-2-175-b18","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1002\/ped4.12297","article-title":"A brief introduction to the FUTang Updating medical REcords (FUTURE) database","volume":"5","author":"Wang","year":"2021","journal-title":"Pediatr Investig"},{"issue":"1","key":"2025012723511472100_i1543-2165-149-2-175-b19","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1002\/gcc.22010","article-title":"Identification of the V600D mutation in exon 15 of the BRAF oncogene in congenital, benign Langerhans cell histiocytosis","volume":"52","author":"Kansal","year":"2013","journal-title":"Genes Chromosomes Cancer"},{"issue":"6","key":"2025012723511472100_i1543-2165-149-2-175-b20","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1002\/gcc.22247","article-title":"MAP2K1 and MAP3K1 mutations in Langerhans cell histiocytosis","volume":"54","author":"Nelson","year":"2015","journal-title":"Genes Chromosomes Cancer"},{"issue":"3","key":"2025012723511472100_i1543-2165-149-2-175-b21","doi-asserted-by":"crossref","first-page":"e89473","DOI":"10.1172\/jci.insight.89473","article-title":"Real-time genomic profiling of histiocytoses identifies early-kinase domain BRAF alterations while improving treatment outcomes","volume":"2","author":"Lee","year":"2017","journal-title":"JCI Insight"},{"issue":"3","key":"2025012723511472100_i1543-2165-149-2-175-b22","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1111\/his.12955","article-title":"Mutually exclusive extracellular signal-regulated kinase pathway mutations are present in different stages of multi-focal pulmonary Langerhans cell histiocytosis supporting clonal nature of the disease","volume":"69","author":"Kamionek","year":"2016","journal-title":"Histopathology"},{"issue":"1","key":"2025012723511472100_i1543-2165-149-2-175-b23","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1038\/s41467-018-03720-z","article-title":"Somatic activating mutations in MAP2K1 cause melorheostosis","volume":"9","author":"Kang","year":"2018","journal-title":"Nat Commun"},{"issue":"14","key":"2025012723511472100_i1543-2165-149-2-175-b24","doi-asserted-by":"crossref","first-page":"5901","DOI":"10.1158\/0008-5472.CAN-10-0192","article-title":"Genomic and biological characterization of exon 4 KRAS mutations in human cancer","volume":"70","author":"Janakiraman","year":"2010","journal-title":"Cancer Res"},{"issue":"2","key":"2025012723511472100_i1543-2165-149-2-175-b25","doi-asserted-by":"crossref","first-page":"455","DOI":"10.3390\/cancers12020455","article-title":"Exon-4 mutations in KRAS affect MEK\/ERK and PI3K\/AKT signaling in human multiple myeloma cell lines","volume":"12","author":"Weissbach","year":"2020","journal-title":"Cancers"},{"issue":"8","key":"2025012723511472100_i1543-2165-149-2-175-b26","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1111\/jop.13048","article-title":"KRAS mutations in brown tumor of the jaws in hyperparathyroidism","volume":"49","author":"Guimaraes","year":"2020","journal-title":"J Oral Pathol Med"},{"issue":"1","key":"2025012723511472100_i1543-2165-149-2-175-b27","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1002\/pbc.26699","article-title":"Novel activating BRAF fusion identifies a recurrent alternative mechanism for ERK activation in pediatric Langerhans cell histiocytosis","volume":"65","author":"Zarnegar","year":"2018","journal-title":"Pediatr Blood Cancer"},{"issue":"5","key":"2025012723511472100_i1543-2165-149-2-175-b28","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1038\/s41591-021-01304-x","article-title":"BRAFV600E-induced senescence drives Langerhans cell histiocytosis pathophysiology","volume":"27","author":"Bigenwald","year":"2021","journal-title":"Nat Med"},{"issue":"2","key":"2025012723511472100_i1543-2165-149-2-175-b29","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1097\/CCO.0000000000000707","article-title":"Mitogen-activating protein kinase pathway alterations in Langerhans cell histiocytosis","volume":"33","author":"Jouenne","year":"2021","journal-title":"Curr Opin Oncol"},{"issue":"24","key":"2025012723511472100_i1543-2165-149-2-175-b30","doi-asserted-by":"crossref","first-page":"3183","DOI":"10.1038\/s41388-018-0171-x","article-title":"Classifying BRAF alterations in cancer: new rational therapeutic strategies for actionable mutations","volume":"37","author":"Dankner","year":"2018","journal-title":"Oncogene"},{"issue":"1","key":"2025012723511472100_i1543-2165-149-2-175-b31","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1002\/ijc.31636","article-title":"A novel fusion gene PLEKHA6-NTRK3 in Langerhans cell histiocytosis","volume":"144","author":"Cai","year":"2019","journal-title":"Int J Cancer"},{"issue":"12","key":"2025012723511472100_i1543-2165-149-2-175-b32","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1038\/s41591-019-0653-6","article-title":"Activating mutations in CSF1R and additional receptor tyrosine kinases in histiocytic neoplasms","volume":"25","author":"Durham","year":"2019","journal-title":"Nat Med"},{"issue":"5","key":"2025012723511472100_i1543-2165-149-2-175-b33","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1016\/j.juro.2010.12.027","article-title":"Requirement for fbp17 in invadopodia formation by invasive bladder tumor cells","volume":"185","author":"Yamamoto","year":"2011","journal-title":"J Urol"},{"issue":"5","key":"2025012723511472100_i1543-2165-149-2-175-b34","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/s12032-018-1132-5","article-title":"High expression of fbp17 in invasive breast cancer cells promotes invadopodia formation","volume":"35","author":"Suman","year":"2018","journal-title":"Med Oncol"},{"issue":"13","key":"2025012723511472100_i1543-2165-149-2-175-b35","doi-asserted-by":"crossref","first-page":"6784","DOI":"10.3390\/ijms22136784","article-title":"Sp1-Induced FNBP1 drives rigorous 3D cell motility in EMT-type gastric cancer cells","volume":"22","author":"Yoon","year":"2021","journal-title":"Int J Mol Sci"},{"issue":"6","key":"2025012723511472100_i1543-2165-149-2-175-b36","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/j.pathol.2020.12.009","article-title":"FNBP1-BRAF fusion in a primary melanoma of the lung","volume":"53","author":"Kervarrec","year":"2021","journal-title":"Pathology"},{"issue":"7132","key":"2025012723511472100_i1543-2165-149-2-175-b37","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1038\/nature05610","article-title":"Patterns of somatic mutation in human cancer genomes","volume":"446","author":"Greenman","year":"2007","journal-title":"Nature"},{"key":"2025012723511472100_i1543-2165-149-2-175-b38","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.humpath.2015.12.029","article-title":"BRAF and MAP2K1 mutations in Langerhans cell histiocytosis: a study of 50 cases","volume":"52","author":"Alayed","year":"2016","journal-title":"Hum Pathol"},{"issue":"7","key":"2025012723511472100_i1543-2165-149-2-175-b39","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1097\/PAS.0000000000001057","article-title":"Frequency of MAP2K1, TP53, and U2AF1 mutations in BRAF-mutated Langerhans cell histiocytosis: further characterizing the genomic landscape of LCH","volume":"42","author":"McGinnis","year":"2018","journal-title":"Am J Surg Pathol"},{"issue":"7834","key":"2025012723511472100_i1543-2165-149-2-175-b40","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1038\/s41586-020-2864-x","article-title":"Single-cell mutation analysis of clonal evolution in myeloid malignancies","volume":"587","author":"Miles","year":"2020","journal-title":"Nature"},{"issue":"31","key":"2025012723511472100_i1543-2165-149-2-175-b41","doi-asserted-by":"crossref","first-page":"2857","DOI":"10.1200\/JCO.19.00456","article-title":"Vemurafenib for refractory multisystem Langerhans cell histiocytosis in children: an international observational study","volume":"37","author":"Donadieu","year":"2019","journal-title":"J Clin Oncol"},{"issue":"1","key":"2025012723511472100_i1543-2165-149-2-175-b42","doi-asserted-by":"crossref","first-page":"261","DOI":"10.4143\/crt.2020.769","article-title":"Effectiveness and safety of dabrafenib in the treatment of 20 Chinese children with BRAFV600E-mutated Langerhans cell histiocytosis","volume":"53","author":"Yang","year":"2021","journal-title":"Cancer Res Treat"},{"key":"2025012723511472100_i1543-2165-149-2-175-b43","doi-asserted-by":"crossref","first-page":"12357","DOI":"10.2147\/OTT.S279093","article-title":"Improvement in pituitary imaging after targeted therapy in three children with BRAF-mutated Langerhans cell histiocytosis with pituitary involvement","volume":"13","author":"Yang","year":"2020","journal-title":"Onco Targets Ther"},{"issue":"7","key":"2025012723511472100_i1543-2165-149-2-175-b44","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1038\/s41591-019-0479-2","article-title":"ARAF recurrent mutation causes central conducting lymphatic anomaly treatable with a MEK inhibitor","volume":"25","author":"Li","year":"2019","journal-title":"Nat Med"},{"issue":"3","key":"2025012723511472100_i1543-2165-149-2-175-b45","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1002\/pbc.25834","article-title":"Diverse cutaneous presentations of Langerhans cell histiocytosis in children: a retrospective cohort study","volume":"63","author":"Morren","year":"2016","journal-title":"Pediatr Blood Cancer"},{"issue":"5","key":"2025012723511472100_i1543-2165-149-2-175-b46","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1177\/1093526619847859","article-title":"BRAF V600E mutation: a significant biomarker for prediction of disease relapse in pediatric Langerhans cell histiocytosis","volume":"22","author":"Ozer","year":"2019","journal-title":"Pediatr Dev Pathol"}],"container-title":["Archives of Pathology &amp; Laboratory Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/meridian.allenpress.com\/aplm\/article-pdf\/149\/2\/175\/3480284\/i1543-2165-149-2-175.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/meridian.allenpress.com\/aplm\/article-pdf\/149\/2\/175\/3480284\/i1543-2165-149-2-175.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T19:41:42Z","timestamp":1764790902000},"score":1,"resource":{"primary":{"URL":"https:\/\/aplm.kglmeridian.com\/view\/journals\/arpa\/149\/2\/article-p175.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,16]]},"references-count":46,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2024,5,16]]},"published-print":{"date-parts":[[2025,2,1]]}},"URL":"https:\/\/doi.org\/10.5858\/arpa.2023-0236-oa","relation":{},"ISSN":["1543-2165","0003-9985"],"issn-type":[{"value":"1543-2165","type":"electronic"},{"value":"0003-9985","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5,16]]}}}